The Cancer Letter

Inside information on cancer research and drug development

Vol.
31
No.
25
June 24, 2005Jun 24, 2005
Free
DOWNLOAD THE PDF

Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say.

FDA orders “limited distribution” for lung cancer drug Iressa.

House approves $210 million for Dept. of Defense cancer research programs.

House Committee on Appropriations approves $28.5 billion for NIH.

House panel investigating NIH handling of tissue specimens.

Login

Looking for IP Login?